These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9179182)

  • 1. Clinical strategies for improving the radiotherapeutic management of prostate cancer.
    Chuba PJ; Forman JD; Ben-Josef E; Hart KH; Porter AT
    Anticancer Res; 1997; 17(3A):1449-54. PubMed ID: 9179182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in prostate cancer radiotherapy: consensus development.
    Lukka H; Warde P; Pickles T; Morton G; Brundage M; Souhami L;
    Can J Urol; 2001 Aug; 8(4):1314-22. PubMed ID: 11564274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy combined with hormonal therapy as treatment method in patients with prostate cancer: still more questions than answers].
    Milecki P
    Przegl Lek; 2005; 62(12):1455-9. PubMed ID: 16786772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachytherapy for clinically localized prostate cancer: optimal patient selection.
    Kollmeier MA; Zelefsky MJ
    Arch Esp Urol; 2011 Oct; 64(8):847-57. PubMed ID: 22052766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technological advances in radiotherapy for the treatment of localised prostate cancer.
    Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
    Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
    Milecki P; Kwias Z; Martenka DJ
    Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan.
    Hachiya T; Akakura K; Saito S; Shinohara N; Sato K; Harada M; Kato T; Okada K
    BJU Int; 2005 Mar; 95(4):534-40. PubMed ID: 15705075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is the best strategy of hormonal therapy in the treatment of locally advanced prostate cancer?].
    Ehara H; Nakano M; Deguchi T
    Hinyokika Kiyo; 2006 Jun; 52(6):473-7. PubMed ID: 16848361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year results.
    Wachter-Gerstner N; Wachter S; Goldner G; Nechvile E; Pötter R
    Strahlenther Onkol; 2002 Oct; 178(10):542-7. PubMed ID: 12386785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.
    Ryan CJ; Zelefsky MJ; Heller G; Regan K; Leibel SA; Scher HI; Kelly WK
    Urology; 2004 Jul; 64(1):90-4. PubMed ID: 15245942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic principles and initial results of adjuvant hormone therapy and irradiation of prostatic carcinoma].
    Dearnaley DP; Shearer RJ; Ellingham L; Gadd J; Horwich A
    Praxis (Bern 1994); 1997 Nov; 86(48):1895-901. PubMed ID: 9480509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of radiotherapy in locally limited prostate cancer].
    Herr HW
    Urologe A; 1991 Nov; 30(6):413-6. PubMed ID: 1771720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
    Lee HK; Adams MT; Motta J
    Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of locally advanced prostate cancer.
    Pisters LL
    Semin Oncol; 1999 Apr; 26(2):202-16. PubMed ID: 10597731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features.
    Vargas C; Martínez A; Galalae R; Demanes J; Harsolia A; Schour L; Nuernberg N; Gonzalez J
    Prostate Cancer Prostatic Dis; 2006; 9(3):245-53. PubMed ID: 16786040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age on the pattern and outcome of external beam radiotherapy for clinically localized prostate cancer.
    Ogawa K; Nakamura K; Onishi H; Koizumi M; Sasaki T; Araya M; Miyabe Y; Otani Y; Teshima T;
    Anticancer Res; 2006; 26(2B):1319-25. PubMed ID: 16619540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
    Pollack A; Horwitz EM
    Nat Clin Pract Oncol; 2005 Jan; 2(1):12-3. PubMed ID: 16264846
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy.
    Yamazaki H; Nishiyama K; Tanaka E; Maeda O; Meguro N; Kinouchi T; Usami M; Kakimoto K; Ono Y; Nishimura T
    Anticancer Res; 2008; 28(6B):3913-20. PubMed ID: 19192649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.